Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2009 2
2010 4
2011 3
2012 4
2013 3
2014 4
2015 1
2016 3
2017 3
2018 4
2019 3
2020 4
2021 6
2022 5
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Development of selective androgen receptor modulators (SARMs).
Narayanan R, Coss CC, Dalton JT. Narayanan R, et al. Among authors: coss cc. Mol Cell Endocrinol. 2018 Apr 15;465:134-142. doi: 10.1016/j.mce.2017.06.013. Epub 2017 Jun 15. Mol Cell Endocrinol. 2018. PMID: 28624515 Free PMC article. Review.
Constitutively Active Androgen Receptor in Hepatocellular Carcinoma.
Montgomery EJ, Xing E, Campbell MJ, Li PK, Blachly JS, Tsung A, Coss CC. Montgomery EJ, et al. Among authors: coss cc. Int J Mol Sci. 2022 Nov 9;23(22):13768. doi: 10.3390/ijms232213768. Int J Mol Sci. 2022. PMID: 36430245 Free PMC article. Review.
Androgen receptor antagonists: a patent review (2008-2011).
Mohler ML, Coss CC, Duke CB 3rd, Patil SA, Miller DD, Dalton JT. Mohler ML, et al. Among authors: coss cc. Expert Opin Ther Pat. 2012 May;22(5):541-65. doi: 10.1517/13543776.2012.682571. Expert Opin Ther Pat. 2012. PMID: 22583332 Review.
Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia.
Vu TT, Kim K, Manna M, Thomas J, Remaily BC, Montgomery EJ, Costa T, Granchie L, Xie Z, Guo Y, Chen M, Castillo AMM, Kulp SK, Mo X, Nimmagadda S, Gregorevic P, Owen DH, Ganesan LP, Mace TA, Coss CC, Phelps MA. Vu TT, et al. Among authors: coss cc. Pharmacol Res. 2024 Jan;199:107048. doi: 10.1016/j.phrs.2023.107048. Epub 2023 Dec 23. Pharmacol Res. 2024. PMID: 38145833 Free PMC article.
Discovery of Anticancer Agents of Diverse Natural Origin.
Aldrich LN, Burdette JE, Carcache de Blanco E, Coss CC, Eustaquio AS, Fuchs JR, Kinghorn AD, MacFarlane A, Mize BK, Oberlies NH, Orjala J, Pearce CJ, Phelps MA, Rakotondraibe LH, Ren Y, Soejarto DD, Stockwell BR, Yalowich JC, Zhang X. Aldrich LN, et al. Among authors: coss cc. J Nat Prod. 2022 Mar 25;85(3):702-719. doi: 10.1021/acs.jnatprod.2c00036. Epub 2022 Feb 25. J Nat Prod. 2022. PMID: 35213158 Free PMC article.
Targeting DNA Damage Repair Functions of Two Histone Deacetylases, HDAC8 and SIRT6, Sensitizes Acute Myeloid Leukemia to NAMPT Inhibition.
Zhang P, Brinton LT, Williams K, Sher S, Orwick S, Tzung-Huei L, Mims AS, Coss CC, Kulp SK, Youssef Y, Chan WK, Mitchell S, Mustonen A, Cannon M, Phillips H, Lehman AM, Kauffman T, Beaver L, Canfield D, Grieselhuber NR, Alinari L, Sampath D, Yan P, Byrd JC, Blachly JS, Lapalombella R. Zhang P, et al. Among authors: coss cc. Clin Cancer Res. 2021 Apr 15;27(8):2352-2366. doi: 10.1158/1078-0432.CCR-20-3724. Epub 2021 Feb 4. Clin Cancer Res. 2021. PMID: 33542077 Free PMC article.
52 results